Innogenetics seals final settlement in hepatitis patent row with Abbott Innogenetics NV has settled its patent dispute with the US pharma giant Abbott over hepatitis C genotyping technology. 22 Apr 2008 News
Innogenetics wins out in patent battle with Abbot The US Appeals Court has upheld the finding that Abbott Laboratories infringed Innogenetics’ hepatitis C virus genotyping patent 23 Jan 2008 News